English
Insider transactions
EDGARHemab Therapeutics Holdings, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-19.
- Open-market purchases (code P)
- 16 transactions, 2,970,541 shares
- Sum of shares × price per share: 55,460,170.87
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–40 of 40
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-24 Filed 2026-09-25 | Walbert Keli Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 36,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 36,000 | Direct (D) | No | F1
| Open filing 0001193125-26-402936 Read from the filing’s XML Dispute this row |
| 2026-06-16 Filed 2026-06-17 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 61,523 | 24.98 | 1,536,844.54Derived: shares × price per share. Exact value 1536844.54. | 6,444,637 | Indirect (I) See footnotes | No | F4, F2, F3
| Open filing 0001231919-26-000665 Read from the filing’s XML Dispute this row |
| 2026-06-15 Filed 2026-06-17 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 6,146 | 24.89 | 152,973.94Derived: shares × price per share. Exact value 152973.94. | 6,383,114 | Indirect (I) See footnotes | No | F1, F2, F3
| Open filing 0001231919-26-000665 Read from the filing’s XML Dispute this row |
| 2026-05-20 Filed 2026-05-21 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 996 | 24.94 | 24,840.24Derived: shares × price per share. Exact value 24840.24. | 6,376,968 | Indirect (I) See footnotes | No | F4, F2, F3
| Open filing 0001231919-26-000521 Read from the filing’s XML Dispute this row |
| 2026-05-19 Filed 2026-05-21 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 3,802 | 24.97 | 94,935.94Derived: shares × price per share. Exact value 94935.94. | 6,375,972 | Indirect (I) See footnotes | No | F1, F2, F3
| Open filing 0001231919-26-000521 Read from the filing’s XML Dispute this row |
| 2026-05-12 Filed 2026-05-14 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 6,387 | 24.90 | 159,036.3Derived: shares × price per share. Exact value 159036.30. | 6,372,170 | Indirect (I) See footnotes | No | F1, F2, F3
| Open filing 0001231919-26-000495 Read from the filing’s XML Dispute this row |
| 2026-05-11 Filed 2026-05-11 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 14,149 | 24.47 | 346,226.03Derived: shares × price per share. Exact value 346226.03. | 6,340,063 | Indirect (I) See footnotes | No | F6, F2, F3
| Open filing 0001231919-26-000475 Read from the filing’s XML Dispute this row |
| 2026-05-11 Filed 2026-05-11 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 25,720 | 25 | 643,000Derived: shares × price per share. Exact value 643000. | 6,365,783 | Indirect (I) See footnotes | No | F7, F2, F3
| Open filing 0001231919-26-000475 Read from the filing’s XML Dispute this row |
| 2026-05-08 Filed 2026-05-11 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 1,483 | 24.98 | 37,045.34Derived: shares × price per share. Exact value 37045.34. | 6,325,914 | Indirect (I) See footnotes | No | F5, F2, F3
| Open filing 0001231919-26-000475 Read from the filing’s XML Dispute this row |
| 2026-05-07 Filed 2026-05-11 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 7,921 | 24.34 | 192,797.14Derived: shares × price per share. Exact value 192797.14. | 6,322,446 | Indirect (I) See footnotes | No | F1, F2, F3
| Open filing 0001231919-26-000475 Read from the filing’s XML Dispute this row |
| 2026-05-07 Filed 2026-05-11 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 1,985 | 24.95 | 49,525.75Derived: shares × price per share. Exact value 49525.75. | 6,324,431 | Indirect (I) See footnotes | No | F4, F2, F3
| Open filing 0001231919-26-000475 Read from the filing’s XML Dispute this row |
| 2026-05-06 Filed 2026-05-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund II, L.P. DirectorRA Capital Nexus Fund IV, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 14,611 | 23.77 | 347,303.47Derived: shares × price per share. Exact value 347303.47. | 6,261,118 | Indirect (I) See footnotes | No | F7, F2, F3
| Open filing 0001231919-26-000457 Read from the filing’s XML Dispute this row |
| 2026-05-06 Filed 2026-05-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund II, L.P. DirectorRA Capital Nexus Fund IV, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 53,407 | 24.83 | 1,326,095.81Derived: shares × price per share. Exact value 1326095.81. | 6,314,525 | Indirect (I) See footnotes | No | F8, F2, F3
| Open filing 0001231919-26-000457 Read from the filing’s XML Dispute this row |
| 2026-05-05 Filed 2026-05-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund II, L.P. DirectorRA Capital Nexus Fund IV, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 87,143 | 24.59 | 2,142,846.37Derived: shares × price per share. Exact value 2142846.37. | 6,236,239 | Indirect (I) See footnotes | No | F6, F2, F3
| Open filing 0001231919-26-000457 Read from the filing’s XML Dispute this row |
| 2026-05-05 Filed 2026-05-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund II, L.P. DirectorRA Capital Nexus Fund IV, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 10,268 | 25 | 256,700Derived: shares × price per share. Exact value 256700. | 6,246,507 | Indirect (I) See footnotes | No | F2, F3
| Open filing 0001231919-26-000457 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-06 | Novo Holdings A/S 10% owner | CConversion of derivative security | Acquired (A) | 4,180,550 | — | — | 4,180,550 | Direct (D) | No | F1
| Open filing 0001388325-26-000023 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-06 | Novo Holdings A/S 10% owner | CConversion of derivative security | Disposed (D) | 23,343 | 0 | — | 0 | Direct (D) | No | F1
| Open filing 0001388325-26-000023 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-06 | Novo Holdings A/S 10% owner | CConversion of derivative security | Disposed (D) | 71,866 | 0 | — | 0 | Direct (D) | No | F1
| Open filing 0001388325-26-000023 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-06 | Novo Holdings A/S 10% owner | CConversion of derivative security | Disposed (D) | 62,121 | 0 | — | 0 | Direct (D) | No | F1
| Open filing 0001388325-26-000023 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-06 | Novo Holdings A/S 10% owner | CConversion of derivative security | Disposed (D) | 32,695 | 0 | — | 0 | Direct (D) | No | F1
| Open filing 0001388325-26-000023 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund II, L.P. DirectorRA Capital Nexus Fund IV, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | CConversion of derivative security | Acquired (A) | 3,607,846 | — | — | 3,607,846 | Indirect (I) See footnotes | No | F1, F2, F3
| Open filing 0001231919-26-000457 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund II, L.P. DirectorRA Capital Nexus Fund IV, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | CConversion of derivative security | Acquired (A) | 1,009,052 | — | — | 1,009,052 | Indirect (I) See footnotes | No | F1, F2, F4
| Open filing 0001231919-26-000457 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund II, L.P. DirectorRA Capital Nexus Fund IV, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | CConversion of derivative security | Acquired (A) | 221,188 | — | — | 221,188 | Indirect (I) See footnotes | No | F1, F2, F5
| Open filing 0001231919-26-000457 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund II, L.P. DirectorRA Capital Nexus Fund IV, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 2,541,250 | 18 | 45,742,500Derived: shares × price per share. Exact value 45742500. | 6,149,096 | Indirect (I) See footnotes | No | F2, F3
| Open filing 0001231919-26-000457 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund II, L.P. DirectorRA Capital Nexus Fund IV, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 133,750 | 18 | 2,407,500Derived: shares × price per share. Exact value 2407500. | 354,938 | Indirect (I) See footnotes | No | F2, F5
| Open filing 0001231919-26-000457 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund II, L.P. DirectorRA Capital Nexus Fund IV, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | CConversion of derivative security | Disposed (D) | 64,680 | — | — | 0 | Indirect (I) See footnotes | No | F1, F2, F3
| Open filing 0001231919-26-000457 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund II, L.P. DirectorRA Capital Nexus Fund IV, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | CConversion of derivative security | Disposed (D) | 27,720 | — | — | 0 | Indirect (I) See footnotes | No | F1, F2, F4
| Open filing 0001231919-26-000457 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund II, L.P. DirectorRA Capital Nexus Fund IV, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | CConversion of derivative security | Disposed (D) | 42,341 | — | — | 0 | Indirect (I) See footnotes | No | F1, F2, F3
| Open filing 0001231919-26-000457 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund II, L.P. DirectorRA Capital Nexus Fund IV, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | CConversion of derivative security | Disposed (D) | 18,146 | — | — | 0 | Indirect (I) See footnotes | No | F1, F2, F4
| Open filing 0001231919-26-000457 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund II, L.P. DirectorRA Capital Nexus Fund IV, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | CConversion of derivative security | Disposed (D) | 56,972 | — | — | 0 | Indirect (I) See footnotes | No | F1, F2, F3
| Open filing 0001231919-26-000457 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-06 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund II, L.P. DirectorRA Capital Nexus Fund IV, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | CConversion of derivative security | Disposed (D) | 10,054 | — | — | 0 | Indirect (I) See footnotes | No | F1, F2, F5
| Open filing 0001231919-26-000457 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-04 | MARAGANORE JOHN Director | CConversion of derivative security | Acquired (A) | 17,974 | — | — | 17,974 | Direct (D) | No | F1
| Open filing 0001193125-26-204048 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-04 | MARAGANORE JOHN Director | CConversion of derivative security | Acquired (A) | 17,974 | — | — | 35,948 | Direct (D) | No | F1
| Open filing 0001193125-26-204048 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-04 | MARAGANORE JOHN Director | CConversion of derivative security | Disposed (D) | 817 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 0 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-204048 Read from the filing’s XML Dispute this row |
| 2026-05-04 Filed 2026-05-04 | MARAGANORE JOHN Director | CConversion of derivative security | Disposed (D) | 817 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 0 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-204048 Read from the filing’s XML Dispute this row |
| 2026-04-30 Filed 2026-05-04 | Behrndt-Eriksen Mads Nikolaj Officer: See Remarks | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 49,016 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 49,016 | Direct (D) | No | F2
| Open filing 0001193125-26-204033 Read from the filing’s XML Dispute this row |
| 2026-04-30 Filed 2026-05-04 | Madigan Catherine Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 49,016 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 49,016 | Direct (D) | No | F2
| Open filing 0001193125-26-204041 Read from the filing’s XML Dispute this row |
| 2026-01-29 Filed 2026-05-04 | Behrndt-Eriksen Mads Nikolaj Officer: See Remarks | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 195,206 | 0 | — | 195,206 | Direct (D) | No | F1
| Open filing 0001193125-26-204033 Read from the filing’s XML Dispute this row |
| 2026-01-29 Filed 2026-05-04 | MARAGANORE JOHN Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 107,338 | 0 | — | 107,338 | Direct (D) | No | F1
| Open filing 0001193125-26-204048 Read from the filing’s XML Dispute this row |
| 2026-01-29 Filed 2026-05-04 | Madigan Catherine Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 145,134 | 0 | — | 145,134 | Direct (D) | No | F1
| Open filing 0001193125-26-204041 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-18. Prior quarter ending 2026-06-30: 9,170 filings read.
Showing 1–50 of 89
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 7,808,627 SH | 240,818,057 dollars | Unchanged Prior quarter: 7,808,627 | Open filing 0001104659-26-128411 Filed 2026-11-16 Dispute this row |
| NOVO HOLDINGS A/S | 4,180,550 SH | 128,928,162 dollars | Unchanged Prior quarter: 4,180,550 | Open filing 0001388325-26-000051 Filed 2026-11-16 Dispute this row |
| FMR LLC Partly reported under another manager | 3,722,599 SH | 114,804,954 dollars | Higher by 24,762 Prior quarter: 3,697,837 | Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row |
| Capital International Investors Partly reported under another manager | 3,601,463 SH | 111,069,119 dollars | Lower by 2,413 Prior quarter: 3,603,876 | Open filing 0001562230-26-000136 Filed 2026-11-12 Dispute this row |
| Deep Track Capital, LP | 3,587,796 SH | 110,647,629 dollars | Lower by 14,297 Prior quarter: 3,602,093 | Open filing 0001856083-26-000006 Filed 2026-11-16 Dispute this row |
| Siren, L.L.C. Partly reported under another manager | 2,366,235 SH | 72,974,687 dollars | Higher by 279,401 Prior quarter: 2,086,834 | Open filing 0002005245-26-000013 Filed 2026-11-12 Dispute this row |
| Avoro Capital Advisors LLC | 1,892,372 SH | 58,360,752 dollars | Lower by 32,778 Prior quarter: 1,925,150 | Open filing 0001104659-26-127608 Filed 2026-11-16 Dispute this row |
| Bain Capital Life Sciences Investors, LLC | 1,650,000 SH | 50,886,000 dollars | Unchanged Prior quarter: 1,650,000 | Open filing 0001193125-26-462089 Filed 2026-11-16 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 1,399,039 SH | 43,146,362 dollars | Higher by 1,115,206 Prior quarter: 283,833 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 932,857 SH | 30,411,138 dollars | Lower by 219,563 Prior quarter: 1,152,420 | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 927,245 SH | 28,596,236 dollars | Higher by 850,345 Prior quarter: 76,900 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 774,064 SH | 23,872,134 dollars | Lower by 6,694 Prior quarter: 780,758 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager | 757,132 SH | 23,351 dollars | Higher by 11,092 Prior quarter: 746,040 | Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row |
| Driehaus Capital Management LLC | 708,166 SH | 21,839,839 dollars | Lower by 7,625 Prior quarter: 715,791 | Open filing 0000938206-26-000066 Filed 2026-11-16 Dispute this row |
| Paradigm Biocapital Advisors LP | 629,347 SH | 19,409,061 dollars | Not in the prior quarter’s filings read | Open filing 0001855655-26-000020 Filed 2026-11-16 Dispute this row |
| Rock Springs Capital Management LP | 575,432 SH | 17,746,323 dollars | Unchanged Prior quarter: 575,432 | Open filing 0001172661-26-005279 Filed 2026-11-16 Dispute this row |
| Bellevue Group AG Partly reported under another manager | 548,935 SH | 16,929,155 dollars | Lower by 1,065 Prior quarter: 550,000 | Open filing 0001104659-26-128575 Filed 2026-11-16 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 502,042 SH | 15,486,576 dollars | Higher by 290,244 Prior quarter: 211,798 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| Affinity Asset Advisors, LLC | 420,000 SH | 12,952,800 dollars | Higher by 281,970 Prior quarter: 138,030 | Open filing 0001011438-26-000687 Filed 2026-11-13 Dispute this row |
| Parkman Healthcare Partners LLC | 329,251 SH | 10,154,101 dollars | Higher by 284,251 Prior quarter: 45,000 | Open filing 0001420506-26-002809 Filed 2026-11-16 Dispute this row |
| DEERFIELD MANAGEMENT COMPANY, L.P. Partly reported under another manager | 275,000 SH | 8,481,000 dollars | Unchanged Prior quarter: 275,000 | Open filing 0001213900-26-120609 Filed 2026-11-16 Dispute this row |
| Schonfeld Strategic Advisors LLC | 169,101 SH | 5,215,073 dollars | Higher by 158,288 Prior quarter: 10,813 | Open filing 0001665241-26-000003 Filed 2026-11-16 Dispute this row |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 164,825 SH | 5,083,203 dollars | Higher by 56,589 Prior quarter: 108,236 | Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 151,558 SH | 4,674,048 dollars | Higher by 111,071 Prior quarter: 40,487 | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| Woodline Partners LP | 150,040 SH | 4,627,234 dollars | Unchanged Prior quarter: 150,040 | Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 137,143 SH | 4,229,490 dollars | Higher by 128,974 Prior quarter: 8,169 | Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 124,792 SH | 3,848,585 dollars | Higher by 12,293 Prior quarter: 112,499 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| UBS Group AG Partly reported under another manager | 106,659 SH | 3,289,364 dollars | Higher by 59,308 Prior quarter: 47,351 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| Ensign Peak Advisors, Inc | 96,447 SH | 2,974,425 dollars | Lower by 18,947 Prior quarter: 115,394 | Open filing 0001454984-26-000011 Filed 2026-11-12 Dispute this row |
| CITADEL ADVISORS LLC Partly reported under another manager | 90,412 SH | 2,788,306 dollars | Lower by 433,038 Prior quarter: 523,450 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| BANK OF AMERICA CORP /DE/ Partly reported under another manager | 84,934 SH | 2,619,364 dollars | Not in the prior quarter’s filings read | Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row |
| Burkehill Global Management, LP | 75,000 SH | 2,313,000 dollars | Unchanged Prior quarter: 75,000 | Open filing 0001013594-26-001202 Filed 2026-11-16 Dispute this row |
| RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager | 67,542 SH | 2,082,995 dollars | Not in the prior quarter’s filings read | Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row |
| XTX Topco Ltd Partly reported under another manager | 59,009 SH | 1,819,838 dollars | Higher by 41,620 Prior quarter: 17,389 | Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row |
| GOLDMAN SACHS GROUP INC Partly reported under another manager | 54,602 SH | 1,683,926 dollars | Not in the prior quarter’s filings read | Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row |
| AMERIPRISE FINANCIAL INC Partly reported under another manager | 53,011 SH | 1,634,859 dollars | Lower by 28,917 Prior quarter: 81,928 | Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row |
| Quadrature Capital Ltd Partly reported under another manager | 50,420 SH | 1,554,953 dollars | Not in the prior quarter’s filings read | Open filing 0001651424-26-000014 Filed 2026-11-13 Dispute this row |
| Bank of New York Mellon Corp Partly reported under another manager | 45,360 SH | 1,398,902 dollars | Not in the prior quarter’s filings read | Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row |
| Ghisallo Capital Management LLC | 40,000 SH | 1,233,600 dollars | Unchanged Prior quarter: 40,000 | Open filing 0001172661-26-005189 Filed 2026-11-16 Dispute this row |
| TD ASSET MANAGEMENT INC | 33,098 SH | 1,078,995 dollars | Unchanged Prior quarter: 33,098 | Open filing 0001193125-26-460060 Filed 2026-11-13 Dispute this row |
| Swiss National Bank | 30,700 SH | 946,788 dollars | Not in the prior quarter’s filings read | Open filing 0001582202-26-000008 Filed 2026-11-12 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 30,137 SH | 929,425 dollars | Higher by 26,059 Prior quarter: 4,078 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| SEVEN GRAND MANAGERS, LLC | 30,000 SH | 925,200 dollars | Unchanged Prior quarter: 30,000 | Open filing 0001420506-26-002775 Filed 2026-11-16 Dispute this row |
| Nuveen, LLC Partly reported under another manager | 29,387 SH | 906,295 dollars | Not in the prior quarter’s filings read | Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row |
| Quantinno Capital Management LP | 28,644 SH | 883,381 dollars | Not in the prior quarter’s filings read | Open filing 0001759654-26-000011 Filed 2026-11-13 Dispute this row |
| GSA CAPITAL PARTNERS LLP | 25,104 SH | 774 dollars | Higher by 7,443 Prior quarter: 17,661 | Open filing 0001362033-26-000013 Filed 2026-11-16 Dispute this row |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE Partly reported under another manager | 24,428 SH | 753,360 dollars | Higher by 5,708 Prior quarter: 18,720 | Open filing 0001145443-26-000111 Filed 2026-11-13 Dispute this row |
| Rafferty Asset Management, LLC | 22,349 SH | 689,243 dollars | Not in the prior quarter’s filings read | Open filing 0001999371-26-025241 Filed 2026-11-13 Dispute this row |
| RHUMBLINE ADVISERS | 21,633 SH | 667,156 dollars | Not in the prior quarter’s filings read | Open filing 0001115418-26-000015 Filed 2026-11-10 Dispute this row |
| Corient Private Wealth LP | 20,164 SH | 621,858 dollars | Not in the prior quarter’s filings read | Open filing 0001948780-26-000012 Filed 2026-11-16 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- ExodusPoint Capital Management, LP 218,287 SH
- BRAIDWELL LP 160,000 SH
- Sixth Street Partners Management Company, L.P. 108,236 SH
- Aberdeen Group plc 52,117 SH
- Opaleye Management Inc. 47,652 SH
- SOROS FUND MANAGEMENT LLC 25,000 SH
- LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 13,183 SH
- Hudson Bay Capital Management LP 12,202 SH
- Weiss Asset Management LP 10,000 SH
- Squarepoint Ops LLC 6,252 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| FMR LLC COMMON STOCK | 10.4 | 4,871,850.00 | 10/30/2026 Filed 2026-11-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0000315066-26-002938 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 10.4 | 4,871,850.00 | 10/30/2026 Filed 2026-11-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0000315066-26-002938 Dispute this row |
| Invus Public Equities, L.P. Common Stock, $0.0001 par value per share | 4.9 | 2,295,029.00 | 08/03/2026 Filed 2026-08-07 | SCHEDULE 13G | Open filing 0002005369-26-000041 Dispute this row |
| Invus Public Equities Advisors, LLC Common Stock, $0.0001 par value per share | 4.9 | 2,295,029.00 | 08/03/2026 Filed 2026-08-07 | SCHEDULE 13G | Open filing 0002005369-26-000041 Dispute this row |
| Invus Global Management, LLC Common Stock, $0.0001 par value per share | 4.9 | 2,295,029.00 | 08/03/2026 Filed 2026-08-07 | SCHEDULE 13G | Open filing 0002005369-26-000041 Dispute this row |
| Siren, L.L.C. Common Stock, $0.0001 par value per share | 4.9 | 2,295,029.00 | 08/03/2026 Filed 2026-08-07 | SCHEDULE 13G | Open filing 0002005369-26-000041 Dispute this row |
| Avicenna Life Sci Master Fund LP Common Stock, $0.0001 par value per share | 0.2 | 71,206.00 | 08/03/2026 Filed 2026-08-07 | SCHEDULE 13G | Open filing 0002005369-26-000041 Dispute this row |
| Avicenna Life Sci Master GP LLC Common Stock, $0.0001 par value per share | 0.2 | 71,206.00 | 08/03/2026 Filed 2026-08-07 | SCHEDULE 13G | Open filing 0002005369-26-000041 Dispute this row |
| Ulys, L.L.C. Common Stock, $0.0001 par value per share | 0.2 | 71,206.00 | 08/03/2026 Filed 2026-08-07 | SCHEDULE 13G | Open filing 0002005369-26-000041 Dispute this row |
| Raymond Debbane Common Stock, $0.0001 par value per share | 5.1 | 2,366,235.00 | 08/03/2026 Filed 2026-08-07 | SCHEDULE 13G | Open filing 0002005369-26-000041 Dispute this row |
| Avoro Capital Advisors LLC Common Stock, par value $0.001 per share | 4.12 | 1,925,150.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G | Open filing 0000902664-26-003462 Dispute this row |
| Avoro Ventures LLC Common Stock, par value $0.001 per share | 2.94 | 1,373,086.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G | Open filing 0000902664-26-003462 Dispute this row |
| Behzad Aghazadeh Common Stock, par value $0.001 per share | 7.06 | 3,298,236.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G | Open filing 0000902664-26-003462 Dispute this row |
| Novo Holdings A/S Common Stock, par value $0.0001 per share | 9.0 | 4,180,550.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G | Open filing 0001388325-26-000046 Dispute this row |
| Capital International Investors Common Stock | 7.7 | 3,603,876.00 | 06/30/2026 Filed 2026-08-12 | SCHEDULE 13G | Open filing 0001562230-26-000124 Dispute this row |
| FMR LLC COMMON STOCK | 7.9 | 3,697,837.00 | 06/30/2026 Filed 2026-08-06 | SCHEDULE 13G | Open filing 0000315066-26-002021 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 7.9 | 3,697,837.00 | 06/30/2026 Filed 2026-08-06 | SCHEDULE 13G | Open filing 0000315066-26-002021 Dispute this row |
| Sofinnova Crossover II SLP Common Stock, par value $0.0001 per share | 5.4 | 2,511,212.00 | 06/30/2026 Filed 2026-08-05 | SCHEDULE 13G | Open filing 0001104659-26-090835 Dispute this row |
| Sofinnova Partners SAS, a French corporation Common Stock, par value $0.0001 per share | 5.4 | 2,511,212.00 | 06/30/2026 Filed 2026-08-05 | SCHEDULE 13G | Open filing 0001104659-26-090835 Dispute this row |
| Antoine Papiernik Common Stock, par value $0.0001 per share | 5.4 | 2,511,212.00 | 06/30/2026 Filed 2026-08-05 | SCHEDULE 13G | Open filing 0001104659-26-090835 Dispute this row |
| Cedric Moreau Common Stock, par value $0.0001 per share | 5.4 | 2,511,212.00 | 06/30/2026 Filed 2026-08-05 | SCHEDULE 13G | Open filing 0001104659-26-090835 Dispute this row |
| Kinam Hong Common Stock, par value $0.0001 per share | 5.4 | 2,511,212.00 | 06/30/2026 Filed 2026-08-05 | SCHEDULE 13G | Open filing 0001104659-26-090835 Dispute this row |
| Joseph Anderson Common Stock, par value $0.0001 per share | 5.4 | 2,511,212.00 | 06/30/2026 Filed 2026-08-05 | SCHEDULE 13G | Open filing 0001104659-26-090835 Dispute this row |
| David Evans Common Stock, par value $0.0001 per share | 5.4 | 2,511,212.00 | 06/30/2026 Filed 2026-08-05 | SCHEDULE 13G | Open filing 0001104659-26-090835 Dispute this row |
| RA Capital Management, L.P. Common Stock, par value $0.0001 per share | 16.6 | 7,729,773.00 | 05/04/2026 Filed 2026-05-11 | SCHEDULE 13G | Open filing 0001346824-26-000127 Dispute this row |
| Peter Kolchinsky Common Stock, par value $0.0001 per share | 16.6 | 7,729,773.00 | 05/04/2026 Filed 2026-05-11 | SCHEDULE 13G | Open filing 0001346824-26-000127 Dispute this row |
| Rajeev Shah Common Stock, par value $0.0001 per share | 16.6 | 7,729,773.00 | 05/04/2026 Filed 2026-05-11 | SCHEDULE 13G | Open filing 0001346824-26-000127 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, par value $0.0001 per share | 13.6 | 6,365,783.00 | 05/04/2026 Filed 2026-05-11 | SCHEDULE 13G | Open filing 0001346824-26-000127 Dispute this row |
| AI DEN-MAB LLC Common stock, par value $0.0001 per share | 10.4 | 4,876,344 | 05/04/2026 Filed 2026-05-11 | SCHEDULE 13D | Open filing 0001193125-26-216973 Dispute this row |
| Access Industries Holdings LLC Common stock, par value $0.0001 per share | 10.4 | 4,876,344 | 05/04/2026 Filed 2026-05-11 | SCHEDULE 13D | Open filing 0001193125-26-216973 Dispute this row |
| AI Biotechnology LLC Common stock, par value $0.0001 per share | 10.4 | 4,876,344 | 05/04/2026 Filed 2026-05-11 | SCHEDULE 13D | Open filing 0001193125-26-216973 Dispute this row |
| Access Industries Management LLC Common stock, par value $0.0001 per share | 10.4 | 4,876,344 | 05/04/2026 Filed 2026-05-11 | SCHEDULE 13D | Open filing 0001193125-26-216973 Dispute this row |
| Len Blavatnik Common stock, par value $0.0001 per share | 10.4 | 4,876,344 | 05/04/2026 Filed 2026-05-11 | SCHEDULE 13D | Open filing 0001193125-26-216973 Dispute this row |
| Deep Track Capital, LP Common stock, $0.0001 par value per share | 8.15 | 3,600,996.00 | 05/01/2026 Filed 2026-05-08 | SCHEDULE 13G | Open filing 0001172661-26-001639 Dispute this row |
| Deep Track Biotechnology Master Fund, Ltd. Common stock, $0.0001 par value per share | 6.75 | 2,981,198.00 | 05/01/2026 Filed 2026-05-08 | SCHEDULE 13G | Open filing 0001172661-26-001639 Dispute this row |
| David Kroin Common stock, $0.0001 par value per share | 8.15 | 3,600,996.00 | 05/01/2026 Filed 2026-05-08 | SCHEDULE 13G | Open filing 0001172661-26-001639 Dispute this row |
| Deep Track Special Opportunities Fund, LP. Common stock, $0.0001 par value per share | 1.40 | 619,798.00 | 05/01/2026 Filed 2026-05-08 | SCHEDULE 13G | Open filing 0001172661-26-001639 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,544,215 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 17,857 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 170,508 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 262,403 |
Filings made before the SEC required XML are listed, not extracted.